Title : Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease.

Pub. Date : 1999 Mar 4

PMID : 10078540






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sildenafil citrate, an orally active, selective inhibitor of phosphodiesterase type 5 (PDE5), has demonstrated excellent efficacy and safety profiles in men with erectile dysfunction of various etiologies. Sildenafil Citrate phosphodiesterase 5A Homo sapiens
2 Sildenafil citrate, an orally active, selective inhibitor of phosphodiesterase type 5 (PDE5), has demonstrated excellent efficacy and safety profiles in men with erectile dysfunction of various etiologies. Sildenafil Citrate phosphodiesterase 5A Homo sapiens